The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 17, 2015
Filed:
Jan. 23, 2014
Applicant:
Oncotherapy Science, Inc., Kanagawa, JP;
Inventors:
Assignee:
OncoTherapy Science, Inc., Kanagawa, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); C07K 14/47 (2006.01); G01N 33/574 (2006.01); C07K 16/18 (2006.01); C12Q 1/48 (2006.01); A61K 31/7088 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 31/7088 (2013.01); C07K 14/47 (2013.01); C07K 14/4748 (2013.01); C12Q 1/485 (2013.01); G01N 33/5011 (2013.01); G01N 33/5035 (2013.01); G01N 33/57415 (2013.01); C12N 2310/14 (2013.01); G01N 2333/9121 (2013.01); G01N 2510/00 (2013.01);
Abstract
The present application provides novel human genes A7322, whose expression is markedly elevated in breast cancer. The present application also provides human genes F3374 whose expression is markedly elevated in breast cancer. These genes and polypeptides encoded thereby can be used, for example, in the diagnosis of breast cancer, and as target molecules for developing drugs against breast cancer. The invention features methods of screening for modulators of the kinase activity of PBK/TOPK. The invention further provides methods of screening for agents to prevent or treat cancer, such as breast cancer.